 Home > Biochemistry News > Biotechnology News > Israel cures 90% of severely ill patients with new coronary disease within 5 days of researching new drug

Israel cures 90% of severely ill patients with new coronary disease within 5 days of researching new drug

 Last Update: 2021-08-29
 Source: Internet
 Author: User

Tags

methylfolate side effects

chloroform side effects

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, Israel’s "Jerusalem Post" reported that the second phase of the clinical trial of the new anti-coronary pneumonia drug "EXO-CD24" developed by the team of Professor Nadir Alber from Izirov Hospital in Israel has again achieved positive results, with more than 90% of participation The critically ill patient in the experiment was cured and discharged within 5 days

Due to the improvement of the Israeli epidemic before, the number of severely ill patients was small, and the second phase of the experiment was carried out in Greece

EXO-CD24 is a combination of CD24 protein and exosomes

In September 2020, the Israeli Ministry of Health approved EXO-CD24 to start clinical trials

Earlier, Albert once stated that, compared to the traditional treatment plan that uses steroids to suppress immune storms, EXO-CD24 is directly inhaled through the trachea to the "heart" of the immune storm-the lungs, using exosomal technology for low-dose local administration , High safety, no adverse reactions and significant effects

It is reported that EXO-CD24 is about to start the next phase of the experiment, during which 155 critically ill patients will participate, two-thirds of which will be treated with EXO-CD24, and one-third will be given a placebo, which is expected to end by the end of this year

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.